Ensysce Biosciences, Inc (ENSC): Price and Financial Metrics
ENSC Price/Volume Stats
| Current price | $0.66 | 52-week high | $2.06 |
| Prev. close | $0.68 | 52-week low | $0.14 |
| Day low | $0.64 | Volume | 1,172,600 |
| Day high | $0.69 | Avg. volume | 8,454,275 |
| 50-day MA | $0.39 | Dividend yield | N/A |
| 200-day MA | $0.56 | Market Cap | 9.10M |
ENSC Stock Price Chart Interactive Chart >
Ensysce Biosciences, Inc (ENSC) Company Bio
Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.
ENSC Price Returns
| 1-mo | 22.45% |
| 3-mo | 49.69% |
| 6-mo | 15.79% |
| 1-year | -24.31% |
| 3-year | -99.80% |
| 5-year | N/A |
| YTD | -37.74% |
| 2023 | -88.22% |
| 2022 | -99.20% |
| 2021 | -62.20% |
| 2020 | -94.03% |
| 2019 | 6.11% |
Loading social stream, please wait...